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Abstract
Vocal cord dysfunction (VCD) is a term that refers to inappropriate adduction of the vocal cords during inhalation
and sometimes exhalation. It is a functional disorder that serves as an important mimicker of asthma. Vocal cord
dysfunction can be difficult to treat as the condition is often underappreciated and misdiagnosed in clinical practice.
Recognition of vocal cord dysfunction in patients with asthma-type symptoms is essential since missing this diagnosis
can be a barrier to adequately treating patients with uncontrolled respiratory symptoms. Although symptoms often
mimic asthma, the two conditions have certain distinct clinical features and demonstrate specific findings on diagnostic
studies, which can serve to differentiate the two conditions. Moreover, management of vocal cord dysfunction
should be directed at minimizing known triggers and initiating speech therapy, thereby minimizing use of
unnecessary asthma medications. This review article describes key clinical features, important physical exam
findings and commonly reported triggers in patients with vocal cord dysfunction. Additionally, this article
discusses useful diagnostic studies to identify patients with vocal cord dysfunction and current management
options for such patients.
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Introduction
Vocal cord dysfunction (VCD) is a term that refers to in-
appropriate adduction of the vocal cords during inhalation
and sometimes exhalation [1]. It is a functional disorder
that serves as an important mimicker of asthma. Con-
comitant vocal cord dysfunction and asthma are seen in a
high degree of patients, up to 50 % of patients in some
studies [2]. Recognition of vocal cord dysfunction in pa-
tients with asthma-type symptoms is often missed and can




Vocal cord dysfunction was first described clinically in
1842 as dysfunction of the laryngeal muscles sometimes
seen in hysterical women [3]. This condition was first vi-
sualized during laryngoscopy in 1869 by MacKenzie,
who made the diagnosis in “hysteric” patients [4]. In
1902, Sir William Osler described VCD as a disorder af-
fecting both the inspiratory and expiratory phases of the
respiratory cycle in the textbook The Principles and
Practice of Medicine [5]. VCD was next described in the
medical literature 70 years later, in 1974, by Patterson
and colleagues in a 33 year old woman with 15 hospitali-
zations for what they termed “Munchausen’s stridor” [6].
Since then, more than 70 terms have been used to de-
scribe abnormal movement of the true vocal cords. Today,
the two most commonly encountered terms in medical lit-
erature are paradoxical vocal fold motion (PVFM) and
vocal cord dysfunction. For the purpose of this article, we
will use the term vocal cord dysfunction (VCD) to
refer to the group of conditions that encompasses all
of these terms.
Clinical presentation
The true incidence of VCD is unknown, but is likely un-
derappreciated in clinical practice. VCD was initially
only thought to exist in the context of psychological ill-
ness or hysteria; however, over the past several decades,
it has been recognized to occur outside of psychological
illness and affect a broader patient base [1]. Brugman
and colleagues investigated 1530 patients with VCD and
found that 65 % were adults above 19 years of age, with
a broad overall age range from 0.02 to 82 years. The me-
dian age range was 36.5 years in adults and 14 years in
pediatric patients [7]. In addition, there tends to be a fe-
male predominance among patients with VCD. Brugman
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and colleagues found a 3:1 female predominance among
their patients, while Morris and colleagues studied 1161
patients in another literature review and found a 2:1 fe-
male predominance [8].
The clinical presentation of vocal cord dysfunction is
widely variable, ranging from no symptoms to mild dys-
pnea to acute-onset respiratory distress that can mimic
an asthma attack [9]. Often, symptoms are periodic and
have been refractory to prior prescribed medical therapy,
such as asthma medications [1]. In a review of 1020 pa-
tients with VCD, Morris and Christopher found that
symptoms were chronic in 860 patients (85 %) and acute
in 151 patients (15 %) [10]. Patient-reported symptoms
include air hunger, sensation of choking, chest tightness,
chest pain, difficulty swallowing, globus sensation, inter-
mittent aphonia or dysphonia, neck or chest retractions,
fatigue and throat clearing. Many of these sensations can
elicit fear, panic and anxiety, which can further worsen
respiratory symptoms [1]. Many studies have described
patients with VCD who have concomitant cough [11, 12].
One theory by Vertigan and colleagues proposed that
chronic cough and VCD are different manifestations of a
single underlying condition. They proposed a model of
chronic cough and VCD on a continuum with pure cough
at one end and pure VCD at the other with some combin-
ation of the two in the middle [13].
Patients with VCD are often misdiagnosed as having
refractory asthma, which can lead to increased health
care costs. Newman and colleagues studied 95 patients
with VCD and found that these patients were misdiag-
nosed for an average of 4.8 years before being diagnosed
with VCD. During this time, they were treated with medi-
cations for severe asthma, sometimes including daily pred-
nisone, and required multiple ER visits, hospitalizations,
and even intubation in 28 % of patients [11]. Traister and
colleagues performed a study comparing 59 patients with
asthma, 43 patients with asthma and VCD and 89 patients
with VCD alone. They found that 42.4 % of all VCD sub-
jects had been previously misdiagnosed with asthma for
an average of 9 years. Those patients with coexisting VCD
and asthma or asthma alone had increased health care
usage compared to patients with VCD alone. Interestingly,
patients with VCD alone who were misdiagnosed as
having asthma had increased medication and health care
usage compared to patients with VCD who were not given
the diagnosis of asthma. This suggests that the main mor-
bidity associated with VCD may lie in its ability to mimic
asthma [14].
Physical examination can help to differentiate patients
with VCD or asthma. Patients often point to or grab
their throat when describing their respiratory symptoms
[15–17]. Rather than helping symptoms, patients often
report that metered dose or powder inhalers can trigger
or exacerbate symptoms, whereas nebulized medications
tend to provide relief [16]. During an acute attack, VCD
often presents with stridor, tachypnea, hoarseness, dys-
phonia, cough, tugging of the neck or upper chest mus-
cles and a look of anxiety or distress [17]. A patient’s
noisy breathing can be reported on physical examination
as “stridor” or “wheeze”. Patients may appear to be in
extremis during an episode and may have complaints
out of proportion to objective findings [18]. Many case re-
ports have described that patients with VCD who require
intubation are easy to ventilate, with quick resolution of
symptoms and normal airway pressures, followed gener-
ally by extubation within 24 h [18].
The differential diagnosis for VCD is broad and in-
cludes any disorder with episodic dyspnea, cough and
wheezing. There are many mimickers of VCD, with
asthma historically on the top of the list. A broad differ-
ential is listed in Table 1 and is important as VCD can
often mimic or coexist with many of these other condi-
tions [1, 17].
Disease mechanism and triggers
Vocal cord dysfunction is due to transient obstruction of
the upper airway associated with paradoxical adduction
(closure) of the vocal folds (cords) and can occur during
one or both stages of the respiratory cycle [1].
The larynx functions to provide protection of the
lower airway, respiration, and phonation, all of which
are regulated partially by involuntary brainstem reflexes.
The protective function of the larynx is strictly reflexive,
whereas the other two functions can be initiated volun-
tarily [19]. Pulmonary protection is mediated by the
glottic closure and cough reflexes to protect the lower
airway from noxious inhaled stimuli and aspiration of
foreign material during respiration [16, 19]. The cough
reflex is usually initiated by an adverse stimulus trigger-
ing one of the many sensory receptors of the larynx [16].
Normally, the vocal cords abduct (open) widely during
inhalation, just before the onset of inspiratory flow, reach-
ing a maximum width at mid-inspiration. During exhal-
ation, vocal cord movement varies significantly between
individuals but generally adducts between 10 and 40 % of
the aperture from end inspiration until approximately two
third of vital capacity is expelled [20].
Vocal cord dysfunction is most likely due to laryngeal
hyperresponsiveness, with increased sensitivity of the la-
ryngeal sensory receptors and heightened response of the
glottic closure and cough reflexes to a number of triggers,
which are discussed later [1]. Maschka and colleagues de-
scribe a number of organic causes of abnormal vocal fold
movement, including primary neurologic disorders, such
as brainstem compression, upper motor neuron injury,
lower motor neuron injury and movement disorders [21].
Vocal fold paralysis caused by head and neck malignancy,
recurrent laryngeal nerve damage during surgery, vocal
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fold paresis from prolonged intubation, and even idio-
pathic vocal fold paralysis can all cause abnormal vocal
fold movement and symptoms similar to those seen in
VCD [18]. However, these organic causes are distinguished
by the fact that they do not generally create intermittent
paroxysms of vocal cord adduction but rather varying
degrees of fairly consistent abnormal movement of the
vocal folds.
VCD episodes frequently begin and end abruptly, so
specific triggers are not always identified [1, 22, 23]. Self-
reported triggers include upper respiratory infections,
occupational exposures, talking, laughing, singing, acid re-
flux, cough, foods, physical exertion, exercise, post nasal
drip, weather changes, emotional stressor, odors, strong
scents and other airborne irritants [12, 24]. Some patients
even report a priming effect where they initially have a
single trigger but eventually develop multiple triggers that
were previously benign [25, 26]. Christopher and Morris
classify triggers for vocal cord dysfunction into exertional,
psychological and irritant categories [18].
Exercise as a trigger
Exertional VCD can be caused by maximal exercise or
athletic competitions but can also be seen during routine
exercise [18]. Exercise-induced VCD can be seen in many
patients who are highly competitive, in elite athletes, and
in active duty military personnel who are required to exer-
cise regularly. Exercise was initially recognized as a cause
of VCD in 1984 in a 33-year-old female competitive run-
ner who developed wheezing during exercise. She was
treated for 10 years for exercise-induced asthma, but upon
further evaluation her methacholine challenge testing was
negative and her post exercise flow-volume loops showed
characteristic flattening of the inspiratory limb [27]. In
1996, McFadden described seven elite athletes who re-
ported a “choking” sensation during exercise but had nor-
mal baseline pulmonary function testing (PFTs) and
negative bronchoprovocation testing. On spirometry they
had the characteristic flattening of the post exercise flow-
volume loop [28]. A study of active duty military patients
with exertional dyspnea found that 12 % of the patients
had VCD triggered by exercise [29].
Psychological triggers
As evidenced by the initial terminology used to describe
VCD, including “hysteric croup”, “Munchausen’s stridor”
and “emotional laryngeal wheezing”, initial reports of
VCD emphasized the dominant underlying psychological
disorders in these patients. It is still thought that psycho-
logical stimuli can trigger VCD, including anxiety dis-
order, stress, depression, somatoform disorder, conversion
disorder, psychiatric illness, history of sexual abuse, and
mass psychogenic illness [18]. In a case series published in
1983 of five patients with “uncontrolled” asthma and dra-
matic wheezing all found to have VCD, a psychiatrist per-
formed personality testing prior to any physiologic or
laryngoscopic studies and established a psychiatric diagno-
sis in four of the five patients [8]. In a review by Lacy and
McManis in the late 1990s, 45 of 48 patients had a psychi-
atric condition, including conversion disorder (52 %),
major depression (13 %), factitious disorder (10 %),
obsessive-compulsive disorder (4 %) or adjustment dis-
order (4 %) [30]. While some studies have suggested that
VCD may be the result of conversion disorder, not all pa-
tients with VCD have an underlying psychiatric ill-
ness [31–33]. A recent prospective study evaluating
psychological disorders in 45 patients with VCD dem-
onstrated a classic conversion profile on Minnesota
Table 1 Differential diagnosis of laryngeal movement
disorders [17, 24]
VCD
Psychogenic Somatoform disorder, conversion disorder, abuse,
anxiety disorder, depression, Munchausen
syndrome, malingering
Exercise Exercise
Irritant Extrinsic (chemical irritants, olfactory stimuli)
Intrinsic (GERD, laryngopharyngeal reflux rhinitis/
post nasal drip, sinusitis)




Prolonged intubation, recurrent laryngeal or vagus
nerve damage during chest or thyroid surgery,
idiopathic
Infectious Epiglottis, bronchiolitis, laryngotracheobronchitis
(croup), laryngitis, pharyngeal abscess, diphtheria,
pertussis, laryngeal papillomatosis
Rheumatologic Rheumatoid cricoarytenoid arthritis, relapsing
polychondritis, laryngeal sarcoidosis




Traumatic Laryngeal injury or fracture, thermal injury, upper
airway hemorrhage, caustic ingestion
Allergic Angioedema, anaphylaxis, exercised induced
anaphylaxis
Neurologic Brainstem stem compression, upper motor neuron
injury, lower motor neuron injury, tic disorders,
multiple sclerosis, postpolio syndrome, multiple
system atrophy, myasthenia gravis, Parkinson
disease, respiratory spasmodic dysphonia, traction
on the recurrent laryngeal nerve, adductor
laryngeal breathing dystonia
Pulmonary Asthma, exercise induced bronchoconstriction,
chronic obstructive pulmonary disease, foreign
body aspiration, hyperventilation syndrome,
pulmonary embolus
Congenital Laryngomalacia, laryngeal cleft, intrathoracic
vascular ring, subglottic stenosis, laryngeal web
Occupational Inhalation injury
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Multiphasic Personality Inventory-2 testing in 40 % of pa-
tients, but 25 % of patients had no evidence of psycho-
pathology [34]. Some investigators actually suggest that
depression and anxiety are often seen in these patients as
a result of their chronic respiratory illness rather than as
the cause of their condition [20, 31, 33].
Irritant triggers
Irritant triggers can be intrinsic, such as gastroesophageal
reflux disease or rhinitis, or extrinsic, including chemical
irritants and olfactory and even visual stimuli [18]. One
theory of vocal cord dysfunction involves laryngeal hyper-
responsiveness and accentuation of the glottic closure re-
flex caused by these intrinsic or extrinsic triggers [35]. The
sensory receptors that mediate the cough and glottic clos-
ure reflexes in the larynx, trachea and larger airways can be
stimulated directly or indirectly via olfactory nerve stimula-
tion or direct stimulation of sensory nerve endings. This
stimulation leads to closure of the vocal folds, and this re-
flex may be accentuated in patients with VCD [15, 16]. Dis-
eases such as postnasal drip, gastroesophageal reflux
disease, pharyngitis, laryngitis and sinusitis can lead to la-
ryngeal inflammation and hyperresponsiveness [36–39].
Diagnosis and testing
The first step in diagnosis of vocal cord dysfunction in-
volves a careful history and physical exam looking for
characteristic features of vocal cord dysfunction. Diagno-
sis of vocal cord dysfunction can be identified with the
use of laryngoscopy, ideally performed after a broncho-
provocation challenge. It can also be suggested by the
appearance of the flow-volume loop obtained through spir-
ometry or pulmonary function testing as well as through
impulse oscillometry, although the latter is not as readily
available [40].
Assessment of symptoms
Characteristic features of vocal cord dysfunction are de-
scribed in the clinical presentation section. Table 2 in-
cludes a list of relevant questions to discuss with patients
to guide diagnosis and differentiate vocal cord dysfunction
from other etiologies. Fowler and colleagues recently pro-
posed a 12-item questionnaire, called the VCDQ, as a
valid tool for symptom monitoring in patients with VCD.
This questionnaire, which incorporates features of many
questions listed in Table 2, showed improvement in scores
after speech therapy. While this scoring system is new and
has not yet been studied in large populations, it may serve
as a novel way to assess severity of disease and monitor re-
sponse to therapy in such patients [41].
Traister and colleagues developed a useful scoring sys-
tem to help distinguish VCD from asthma called the
Pittsburgh VCD index. This simple, valid and easy to use
clinical tool assigns patients a weighted score based on
symptoms of throat tightness (score of 4) and dysphonia
(score of 2), the absence of wheezing (score of 2) and
the presence of odors as a trigger for symptoms (score
of 3). A cutoff of ≥ 4 yielded an 83 % sensitivity and 95 %
specificity for the diagnosis of VCD. Upon application to
a population with known VCD, this scoring system cor-
rectly diagnosed VCD in 77.8 % of patients. Of course,
since many patients have coexistent VCD and asthma,
further diagnostic tests should be performed if a strong
suspicion for asthma exists [42].
Flexible laryngoscopy
Endoscopic examination with direct visualization of the
vocal folds via flexible, transnasal fiber-optic laryngos-
copy during an acute attack is the gold standard for
diagnosis of VCD [8, 11, 31]. The presence of inspiratory
adduction is key to making the diagnosis [18]. Brugman
found complete inspiratory vocal fold adduction at mid-
inspiration was the most common laryngoscopy finding
in 66 % of adult and pediatric patients with known VCD
[7]. Figure 1a shows images from the laryngoscopy of a
patient with paradoxical vocal fold adduction during
mid-inspiration, whereas Fig. 1b shows laryngoscopy im-
ages from the same patient following successful speech
therapy.
The endoscopic examination of patients with VCD is
frequently normal when patients are symptom-free. Pa-
tients should be instructed to perform various maneu-
vers during laryngoscopy including sniff, sequential
Table 2 Pertinent questions for evaluation of VCD [41]
1. Do you feel like your symptoms are confined to your throat or upper
chest?
2. Do you feel like there is a restriction in your throat or upper chest
preventing you from getting air past a certain point?
3. Do you have shortness of breath when breathing in?
4. Do you have a sudden onset of your attacks?
5. Do you a sensation of something in your throat you are unable to
clear?
6. Does your voice change when you have an attack?
7. Do you feel your breathing is loud or noisy during attacks?
8. Do specific triggers cause your attacks?
9. Do you feel your symptoms have not been understood correctly?
10. Do you have difficulty with light pressure, such as tight clothes or
bending your neck?
11. Are your attacks impacting your social life?
12. Do asthma medications help?
13. Do use of your asthma inhalers sometimes make symptoms worse?
14. Do you ever feel lightheaded or dizzy during attacks?
15. Do you have numbness or tingling in your hands, feet or lips with
attacks?
16. When your symptoms start, do you generally cough?
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phonation, normal breathing, panting and repetitive
deep breaths in order to fully evaluate vocal cord move-
ment [8, 18, 20]. A forced expiratory and inspiratory
vital capacity maneuver that simulates generation of a
flow-volume loop may be helpful in discovering abnor-
mal vocal cord movement [18]. VCD occurring exclu-
sively during expiration is uncommon and should not be
confused with glottic narrowing that occurs in asth-
matics to allow for intrinsic positive end-expiratory pres-
sure (PEEP) [8].
Bronchoprovocation challenge
Performing a laryngoscopy immediately after a bronchial
challenge can help determine whether a patient has
asthma, VCD, or both [1]. Patients with VCD often show
inappropriate vocal fold movement during inspiration or
expiration when laryngoscopy is performed immediately
following a bronchoprovocation challenge with metha-
choline. However, patients who are asymptomatic may
show normal vocal fold movement. Therefore, a negative
laryngoscopy in an asymptomatic patient does not rule
out VCD [15]. Nonetheless, bronchial provocation with
methacholine has a high negative predictive value and
can be helpful in ruling out the diagnosis of asthma [43].
In patients with a compelling history who fail to react to
methacholine, an irritant challenge under close observa-
tion to a known trigger or provocation with exercise
may be indicated to elicit symptoms [19, 20, 28, 35].
Pulmonary function testing
A reported characteristic finding in VCD is a highly vari-
able, non-reproducible and abnormally shaped inspiratory
loop on spirometry consistent with a variable extrathor-
acic obstruction, as described by Miller and Hyatt [15, 44].
Morris et al. reviewed 1500 cases of VCD in the published
literature and found that 28 % of reported VCD patients
had flow-volume loop truncation on spirometry [8]. As
seen in Fig. 2, the inspiratory flow loop can show flatten-
ing, truncation, and/or saw tooth pattern in patients with
VCD, either during an acute VCD attack or even when pa-
tients are asymptomatic [15, 16, 20]. Blunting of both in-
spiratory and expiratory loops, on the other hand, is
consistent with a fixed obstruction and should be further
evaluated radiographically or endoscopically for a fixed
process rather than a functional disorder [20].
Another useful measure in pulmonary function testing
is the FEF50/FIF50 ratio, which is usually less than one
in normal individuals. In patients with inspiratory VCD,
this ratio is usually greater than 1 because truncation of
the inspiratory loop reduces the FIF50. For patients with
VCD and concomitant expiratory obstruction or comor-
bid asthma, however, this ratio may be difficult to inter-
pret [8, 16, 45].
Impulse oscillometry
Komarow and colleagues found that impulse oscillome-
try (IOS) exhibits a characteristic impedance pattern in
patients with VCD, verified by laryngoscopy. This may
offer a rapid, noninvasive adjunct to diagnose patients
with VCD [40] The main drawback to this type of test-
ing, however, is the impulse oscillometers are not readily
available.
Treatment and management
Despite the typically benign and self-limited episodes,
VCD can lead to severe symptoms, the impression of
impending respiratory failure, and even emergent intub-
ation or tracheostomy. Management of VCD often re-
quires a multidisciplinary approach involving the primary
care physician, pulmonologist, allergist, otolaryngologist,
gastroenterologist, neurologist, psychiatrist or psycholo-
gist, speech pathologist, and athletic trainer [16, 46].
The management of VCD, especially in the acute set-
ting, requires establishing the correct diagnosis. In the
Fig. 1 a Images taken during laryngoscopy showing paradoxical adduction detected during mid-inspiration in a patient with vocal cord dysfunction
b Appropriate movement of the vocal cords during mid-inspiration in the same patient following speech therapy
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absence of impending respiratory failure, performing a
laryngoscopy while symptomatic is rapid, safe and in-
formative in most patients. Once the diagnosis is estab-
lished, treatment should be aimed at acutely relieving
airway obstruction [18]. Asthma medications, including
inhaled bronchodilators and corticosteroids, should be
used only if the diagnosis is unclear, but patients may
have minimal response to them [18]. Once the diagnosis
of VCD is confirmed, the first step is to reassure patients
that the condition is benign and self-limited. While the
use of medications can be attempted, effective long-term
therapy requires psychosocial support, speech therapy
and even biofeedback.
Patient education
Patient education is a crucial component of treatment.
Knowledge of normal physiology and functional abnor-
malities causing symptoms can help patients accept their
diagnosis and gain control over this disorder. Allowing
patients to view their laryngoscopy findings often en-
hances understanding and acceptance. Patients previ-
ously misdiagnosed with asthma instead of VCD should
have unnecessary medications discontinued gradually
and under the care of their physician [8, 10, 33].
Medications
Sedation with benzodiazepines has proven successful in
some patients, especially when underlying anxiety is a
contributing factor [8, 12]. Heliox, a helium/oxygen
mixture that leads to a reduction of air density, decreases
turbulent flow, and reduces work of breathing, has shown
favorable responses in acute VCD episodes and has even
demonstrated a sustained response after discontinuation
in many cases [10]. An invasive and rarely used treatment
modality is laryngeal injection of botulinum toxin type A,
which prevents acetylcholine release at nerve endings,
leading to chemical denervation and paralysis of the vocal
fold in the open position [8, 9]. While this has been suc-
cessfully used to treat spasmodic dystonia [33], a review
by Morris and colleagues in 2006 found only 9 reported
cases of botulinum toxin used to treat VCD [8]. Given the
risk associated with paralyzing vocal cords in an open pos-
ition, it should be reserved for patients refractory to all
other therapies or those considering tracheostomy [8, 9].
Speech therapy and psychotherapy
The most common long-term treatment is speech ther-
apy and psychotherapy. Speech therapy consists of a de-
tailed assessment of patient’s symptoms and triggers,
followed by a comprehensive treatment that is tailored
to the individual patient [17]. Patients are educated about
the pathophysiology of VCD, are provided supportive
counseling, and are educated about suppression of laryn-
geal abusive behaviors (i.e., cough and throat clearing),
voice therapy, respiratory retraining, and desensitization
to specific irritants. They are taught various breathing
techniques, known as quick-release techniques, which act
to rapidly release the vocal folds from the paradoxical
Fig. 2 a Normal flow volume loop in asymptomatic patient. b Example of flattening, early truncation and saw-tooth pattern of inspiratory limb of
flow volume loop in a patient with vocal cord dysfunction
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movement responsible for symptoms of VCD. These exer-
cises focus on pursed-lip breathing using abdominal sup-
port, with a focus on relaxation. Patients are encouraged
to practice this technique with 5 repetitions 20 times per
day to assist with laryngeal relaxation and retraining
and to ensure that patients can respond automatically
when acutely symptomatic [17]. Patient progress can be
followed clinically or with more objective approaches, such
as the VCDQ described above, which has shown improve-
ment in scores after speech therapy [41]. In addition to
speech therapy, patients may benefit from psychological
counseling, which lacks a systematic study but may be
warranted in those whose VCD is related to an underlying
psychiatric condition [33, 47].
Biofeedback
Biofeedback and hypnosis have also shown some benefit
in patients with VCD [47–50]. McFadden and Zawakski
found that four of nine patients with exercise induced
VCD had rapid resolution of symptoms after basic bio-
feedback [28]. In another study, the use of hypnosis in
29 VCD patients showed improvement in 31 % and
resolution in another 38 % [51].
Conclusions
Vocal cord dysfunction can be difficult to treat as the
condition is often underappreciated and misdiagnosed in
clinical practice. Although symptoms often mimic asthma,
VCD and asthma have certain distinct clinical features and
specific findings on diagnostic studies, which can serve to
differentiate the two conditions. Early recognition and ac-
curate diagnosis of vocal cord dysfunction can prevent im-
proper treatment and, therefore, minimize escalated health
care costs. The Pittsburgh VCD index and the VCDQ may
serve as useful tools to differentiate asthma and VCD and
to measure symptom improvement after treatment. While
speech therapy is currently the mainstay of treatment, bio-
feedback and pharmacotherapy have been successful in se-
lect patients. Since intrinsic and extrinsic triggers can
exacerbate laryngeal hyper-responsiveness, a focus on min-
imizing such triggers can also serve to improve symptoms.
Further studies are needed to investigate novel therapies
for refractory patients.
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